Other
The company warns of unauthorized individuals posting fraudulent job opportunities under CatenaBio's name and directs users to the official contact form / FTC reporting channels.
SourceUsing protein coupling to build new therapies
Company research
Public company, workplace, funding, and market signals
Overview
UC Berkeley spinout developing its CysTyr® precision-conjugation platform and Multi-Payload Conjugates (MPCs) for next-generation antibody-drug conjugates, initially focused on hard-to-treat solid tumors and with broader applications in oncology, autoimmune disease, and vaccine development.
Primary product
Multi-Payload Conjugates (MPCs) built on the CysTyr® conjugation platform
Founded
2020
Headquarters
Berkeley, California, United States
Team size
10-20
Work style
Onsite
Industry
Biotechnology Research
Sub-industry
Antibody-drug conjugates / protein conjugation therapeutics
Offices
Open Positions
0 jobs at Catena Biosciences
No open positions
Check back later for new openings